A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumab-Reference-Cited by-同舟云学术

A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumab

Published:2024-02-14 Issue:2 Volume:13 Page:158-161
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Kurokawa Masahiro,Ikarashi Daiki,Kato Renpei,Kanehira Mitsugu,Fukagai Takashi,Obara Wataru

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13691-024-00657-7.pdf

Reference13 articles.

1. Klatte T, Pantuck AJ, Riggs SB et al (2007) Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 178:1189–1195. https://doi.org/10.1016/j.juro.2007.05.134

2. Miki J, Yamasaki T, Komai Y et al (2022) Jikei-Kyoto-Osaka-Nagasaki-Ganken Group (J-KONG Group): Intra- and post-operative management of pancreatic injury during laparoscopic nephrectomy. Int J Urol 29:905–907. https://doi.org/10.1111/iju.14899

3. Ged Y, Lee CH (2022) Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma. Expert Rev Anticancer Ther 22:1049–1059. https://doi.org/10.1080/14737140.2022.2128336

4. Yoshida K, Hata K, Iizuka J et al (2022) Immune checkpoint inhibitor combination therapy for renal cell carcinomas with concomitant inferior vena cava thrombi. In Vivo. https://doi.org/10.21873/invivo.12798

5. Hara T, Terakawa T, Hyodo T et al (2021) Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy. Urol Case Rep 9(39):101800. https://doi.org/10.1016/j.eucr.2021.101800. (PMID:34430210;PMCID:PMC8365366)